Home
/
Artiva Biotherapeutics, Inc.
/
Financials
/
Quarterly
Artiva Biotherapeutics, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Artiva Biotherapeutics, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2024
$251.0K
Nov 12, 2025
Q2
2025
Jun 30, 2024
$251.0K
Aug 6, 2025
Q1
2025
Mar 31, 2024
$251.0K
May 8, 2025
Q3
2024
Sep 30, 2023
$26.66M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$3.50M
Aug 29, 2024
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2023
$26.66M
Nov 12, 2024
Q2
2024
Jun 30, 2023
$3.50M
Aug 29, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($21.53M)
Nov 12, 2025
Q3
2025
Jun 30, 2025
($21.25M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($21.25M)
Aug 6, 2025
Q3
2025
Mar 31, 2025
($20.31M)
Nov 12, 2025
Q2
2025
Mar 31, 2025
($20.31M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($20.31M)
May 8, 2025
Q3
2025
Sep 30, 2024
($17.47M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($17.84M)
Aug 6, 2025
Q3
2025
Jun 30, 2024
($17.84M)
Nov 12, 2025
Q3
2025
Mar 31, 2024
($13.96M)
Nov 12, 2025
Q2
2025
Mar 31, 2024
($13.96M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($13.96M)
May 8, 2025
Q3
2024
Sep 30, 2023
$11.28M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.28M)
Aug 29, 2024
Q3
2024
Jun 30, 2023
($11.28M)
Nov 12, 2024
Q3
2024
Mar 31, 2023
($16.72M)
Nov 12, 2024
Q2
2024
Mar 31, 2023
($16.72M)
Aug 29, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($22.90M)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($22.81M)
Aug 6, 2025
Q1
2025
Mar 31, 2025
($22.17M)
May 8, 2025
Q3
2025
Sep 30, 2024
($18.34M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($16.19M)
Aug 6, 2025
Q1
2025
Mar 31, 2024
($14.49M)
May 8, 2025
Q3
2024
Sep 30, 2023
$10.81M
Nov 12, 2024
Q2
2024
Jun 30, 2023
($11.82M)
Aug 29, 2024